NV-HOHEM
8.1.2020 10:28:04 CET | Business Wire | Press release
CES 2020 will be held on January 7-10, 2020 in Las Vegas. During this grand gathering of global technology players, Hohem Technology Co., Ltd. (Hohem), as a dark horse in the portable gimbal industry, drew great attention of multiple buyers, journalists and third parties to its innovative and all-new smartphone gimbal iSteady X.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200108005299/en/
iSteady X, which will be officially launched in February 2020, is designed to solve the pain points of users with a foldable design and multiple creative functions like a 15-second video sharing button. Here are some highlights of the product.
The lightest
iSteady X stands out among others for it is the world's first lightweight handheld smartphone gimbal. Compared to traditional smartphone gimbals, iSteady X weighs only 249g, making it the world’s lightest three-axis smartphone gimbal. The lighter weight makes it easier to record your everyday life and journey.
Smaller
The foldable design makes iSteady X more compact and streamlined. Measuring only the size of a palm when folded up, it is convenient for users to carry around, hold in their hands, or put in their pockets, making it the ideal gadget for vloggers or those who like shooting with their smartphones.
Moment Mode, New Community APP
iSteady X has a set of buttons that allow users to instantly master the operation without pre-learning. Just by pressing one button, users can launch multiple modes including Moment Mode, Face-Tracking iSteady X is equipped with first-class anti-shake movement, the newest anti-shake algorithm iSteady, and the enhanced motor control scheme, so as to support a maximum load of 280g.
More information will not be released until its official release at CES 2020. Visitors at CES 2020 may go to booth 25953 to have a hand-on experience of Hohem products. Follow Hohem on Facebook : https://www.facebook.com/HohemGlobal/
About Hohem
Established in 2014, Hohem Technology Co., Ltd. (Hohem), adheres to its motto: Make the Moment, Enjoy it! It focuses on R&D and production of smart gimbals such as action camera gimbals, smartphone gimbals and DSLR gimbals.
The company has a solid technical foundation and has successfully launched the world’s first smartphone gimbal with face recognition function. Hohem is committed to providing users with simplistic, functional, and creative products. For details: https://www.hohem-tech.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20200108005299/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ABB Extends Engagement with Wipro to Deliver and Enhance Global Digital Workplace Services2.9.2026 15:30:00 CEST | Press release
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading AI-powered technology services and consulting company, has renewed its long-standing Digital Workplace Services contract with ABB, a global technology leader in electrification and automation. Building on an established relationship spanning multiple years, Wipro will continue delivering end-to-end AI-enabled Digital Workplace Services for ABB's global operations while further enhancing employee experience through advanced automation, AI-powered service capabilities, and workplace modernization initiatives. Powered by Wipro Intelligence™, the unified suite of AI platforms, solutions and transformative offerings, this engagement will modernize ABB’s digital workplace with AI-led, experience-centric capabilities delivered through Wipro’s AI Live Workspace™ and Digital Workplace Services offerings and operationalized through WINGS, Wipro’s AI-powered delivery platform for operations. Through SmartOps, Wipro’s AIOps capability,
Egon Zehnder Names Ayşe Güçlü Onur Global Human Resources Practice Leader2.9.2026 15:00:00 CEST | Press release
Egon Zehnder has appointed Ayşe Güçlü Onur as Global Leader of its Human Resources Practice. This appointment comes as companies and boards increasingly look to CHROs to help shape business strategy, lead transformation, build leadership pipelines, and navigate major shifts in culture and the workforce. "CHROs used to be evaluated by how well they supported the business. Today, the best drive it," said Onur. "Our role is to help CHROs move from a seat at the table to a hand in business growth. We help them connect leadership decisions, talent, and culture directly to elevated performance. That's the shift Egon Zehnder is built to guide with our leadership advisory services." Egon Zehnder’s Human Resources Practice partners with companies to discover, develop, and transform future-ready CHROs, helping them shape the future of the function. This includes executive search, leadership assessment and development, board effectiveness, culture, succession planning, organizational transformati
Safe Software to Increase Global Headcount by Over 15% as Demand for AI-Ready Data Grows2.9.2026 15:00:00 CEST | Press release
The FME creator is recruiting for more than 60 roles across the UK, US and Canada before the end of December, less than a year after crossing $100M in revenue Safe Software, the creator of FME, the only All-Data, Any-AI enterprise integration platform with true support for spatial data, today announced it is recruiting for more than 60 roles throughout the remainder of 2026. The hiring will take the company past 400 employees, increasing headcount by over 15%, with new positions across the United Kingdom, the United States and Canada. The expansion follows a year in which Safe crossed $100 million in annual revenue, growing close to 20 percent year over year and moving ahead of schedule on its target of $250 million by 2028. The company also grew its employee base by over 20% in the same period. "The incredible growth that we’ve seen over the last 30+ years at Safe has always been a testament to the great people behind what we do," said Don Murray, Co-Founder and CEO of Safe Software.
Owkin to License K Pro AI Scientist and Multimodal Oncology and Immunology Datato Boehringer Ingelheim2.9.2026 14:00:00 CEST | Press release
Owkin, the agentic AI company striving to transform drug discovery and development for biopharma, today announced a license agreement with Boehringer Ingelheim for K Pro, Owkin’s AI Scientist, together with multimodal patient data, aiming to speed up the discovery process across multiple indications in oncology and immunology. This agreement builds upon an initial pilot undertaken by Owkin with Boehringer in 2025. In that pilot Owkin delivered deep spatial insights into the tumor microenvironment of a gene target through its MOSAIC dataset. Under the new agreement, Owkin will license multimodal oncology data to Boehringer and will generate new multimodal data in immunology. Owkin licenses, sources and generates multimodal patient data in collaboration with its global patient data network. Boehringer Ingelheim’s teams will access and analyze this data through K Pro, which provides a single environment to interrogate data and run reproducible analyses. K Pro’s reasoning capabilities supp
Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience2.9.2026 14:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, SSE: 688796; HKEX: 02315) today announced that it has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical Co., Ltd. (“Qilu Pharmaceutical”) for a fully human VHH antibody molecule. Under the agreement, Biocytogen will grant Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody molecule to support its research and development of innovative therapeutics in the neuroscience field. The licensed VHH antibody molecule was generated from Biocytogen’s proprietary RenNano® platform. The RenNano® platform is designed to discover fully human VHH antibody molecules with favorable specificity, binding affinity, and developability, and can generate molecular building blocks for the design and development of VHH antibodies, bispecific/multispecific antibodies, antibody-drug conjugates, and other innovative modalities. Through this license, Qilu Pharmaceutical may advance the research and development o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom